Total Payments
$191,862
2022 Payments
$271.51
Companies
50
Transactions
912
Medicare Patients
1,193
Medicare Billing
$150,777
Payment Breakdown by Category
Other$139,443 (72.7%)
Consulting$21,951 (11.4%)
Food & Beverage$17,986 (9.4%)
Travel$10,860 (5.7%)
Research$1,250 (0.7%)
Education$371.95 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $139,443 | 87 | 72.7% |
| Consulting Fee | $21,951 | 12 | 11.4% |
| Food and Beverage | $17,986 | 766 | 9.4% |
| Travel and Lodging | $10,860 | 38 | 5.7% |
| Unspecified | $1,250 | 2 | 0.7% |
| Education | $371.95 | 7 | 0.2% |
Payments by Type
General
$190,612
910 transactions
Research
$1,250
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $59,968 | 118 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $39,317 | 117 | $0 (2021) |
| Biogen, Inc. | $26,780 | 151 | $0 (2020) |
| Genentech USA, Inc. | $22,850 | 81 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $11,447 | 87 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $11,330 | 22 | $0 (2020) |
| Mallinckrodt LLC | $9,031 | 24 | $0 (2018) |
| EMD Serono, Inc. | $6,702 | 56 | $0 (2021) |
| UCB, Inc. | $512.27 | 35 | $0 (2019) |
| Genentech, Inc. | $421.60 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $271.51 | 3 | GENZYME CORPORATION ($253.81) |
| 2021 | $6,987 | 14 | Genentech USA, Inc. ($5,454) |
| 2020 | $9,065 | 21 | EMD Serono, Inc. ($4,737) |
| 2019 | $35,847 | 216 | Alexion Pharmaceuticals, Inc. ($11,167) |
| 2018 | $52,776 | 308 | GENZYME CORPORATION ($13,135) |
| 2017 | $86,916 | 350 | GENZYME CORPORATION ($31,532) |
All Payment Transactions
912 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2022 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $137.84 | General |
| Category: Neurology | ||||||
| 06/08/2022 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $115.97 | General |
| Category: Neurology | ||||||
| 01/04/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2021 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2021 | Genentech USA, Inc. | OCREVUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,530.00 | General |
| Category: Immunology | ||||||
| 12/15/2021 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Immunology | ||||||
| 12/01/2021 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Neurology | ||||||
| 10/28/2021 | Genentech USA, Inc. | OCREVUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,530.00 | General |
| Category: Immunology | ||||||
| 10/28/2021 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $51.33 | General |
| Category: Immunology | ||||||
| 10/07/2021 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $116.12 | General |
| 09/30/2021 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $93.37 | General |
| Category: Immunology | ||||||
| 07/28/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2021 | EMD Serono, Inc. | — | Food and Beverage | In-kind items and services | $111.88 | General |
| 05/26/2021 | Genentech USA, Inc. | OCREVUS (Biological), Enspryng | Food and Beverage | In-kind items and services | $82.78 | General |
| Category: Immunology | ||||||
| 04/09/2021 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Neurology | ||||||
| 01/25/2021 | Genentech, Inc. | OCREVUS (Biological) | Education | In-kind items and services | $49.95 | General |
| Category: Immunology | ||||||
| 01/22/2021 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $577.50 | General |
| Category: Neurology | ||||||
| 06/12/2020 | EMD Serono, Inc. | — | Education | In-kind items and services | $51.00 | General |
| 03/18/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,300.00 | General |
| Category: Neurology | ||||||
| 03/03/2020 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $127.35 | General |
| 03/03/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: Neurology | ||||||
| 02/11/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,114.00 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $267.92 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Case report from clinical practice - no protocol number | GENZYME CORPORATION | $732.96 | 1 |
| Case Study | GENZYME CORPORATION | $517.40 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 304 | 417 | $162,070 | $39,284 |
| 2021 | 4 | 364 | 506 | $205,575 | $53,041 |
| 2020 | 11 | 525 | 683 | $250,845 | $58,452 |
Total Patients
1,193
Total Services
1,606
Medicare Billing
$150,777
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 235 | 345 | $129,375 | $31,759 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $17,250 | $3,529 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $6,930 | $1,885 | 27.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 17 | $4,335 | $1,121 | 25.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 11 | 11 | $4,180 | $989.01 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 259 | 401 | $150,375 | $39,794 | 26.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 59 | 59 | $33,925 | $7,688 | 22.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 33 | $16,335 | $4,360 | 26.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 13 | 13 | $4,940 | $1,199 | 24.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 235 | 338 | $126,750 | $28,597 | 22.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 105 | 105 | $60,375 | $13,830 | 22.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 34 | $16,920 | $3,664 | 21.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 29 | 34 | $9,565 | $3,163 | 33.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 39 | 42 | $5,925 | $2,715 | 45.8% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2020 | 11 | 11 | $9,845 | $2,168 | 22.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 24 | 24 | $8,880 | $1,951 | 22.0% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2020 | 12 | 12 | $5,700 | $1,089 | 19.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 13 | $3,315 | $764.54 | 23.1% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2020 | 12 | 21 | $2,100 | $305.06 | 14.5% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2020 | 13 | 49 | $1,470 | $204.56 | 13.9% |
About Dr. Jeffrey Gross, M.D
Dr. Jeffrey Gross, M.D is a Neurology healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770549180.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Gross, M.D has received a total of $191,862 in payments from pharmaceutical and medical device companies, with $271.51 received in 2022. These payments were reported across 912 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($139,443).
As a Medicare-enrolled provider, Gross has provided services to 1,193 Medicare beneficiaries, totaling 1,606 services with total Medicare billing of $150,777. Data is available for 3 years (2020–2022), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Fairfield, CT
- Active Since 04/25/2006
- Last Updated 08/01/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1770549180
Products in Payments
- LEMTRADA (Drug) $32,017
- GILENYA (Drug) $30,676
- AUBAGIO (Drug) $18,019
- OCREVUS (Biological) $17,764
- TECFIDERA (Drug) $16,641
- COPAXONE (Drug) $10,745
- TYSABRI (Biological) $9,858
- DISEASE STATE (Drug) $9,567
- ACTHAR (Biological) $9,053
- Mavenclad (Drug) $5,886
- Non-Covered Product (Drug) $5,140
- SOLIRIS (Drug) $2,542
- MAYZENT (Drug) $1,787
- Rebif (Biological) $532.17
- Briviact (Drug) $353.29
- MS DISEASE STATE (Drug) $299.62
- AMPYRA (Drug) $283.77
- AUSTEDO (Drug) $255.61
- AJOVY (Drug) $244.39
- AIMOVIG (Biological) $225.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fairfield
Peter Mcallister, M.d, M.D
Neurology — Payments: $2.3M
Neurology $2.3M
P. Christopher Gottschalk, M.d, M.D
Neurology — Payments: $400,249
Neurology $400,249
Dr. Nicholas Blondin, M.d, M.D
Neurology — Payments: $144,704
Neurology $144,704
Srinath Kadimi, M.d, M.D
Neurology — Payments: $44,527
Neurology $44,527
Dario Zagar, M.d, M.D
Neurology — Payments: $19,926
Neurology $19,926
Mrs. Ruby Ali, M.d, M.D
Neurology — Payments: $18,050
Neurology $18,050